These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3105452)

  • 1. In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii.
    Hofflin JM; Remington JS
    Antimicrob Agents Chemother; 1987 Feb; 31(2):346-8. PubMed ID: 3105452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of roxithromycin against Toxoplasma gondii in murine models.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():69-74. PubMed ID: 3429388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of roxithromycin (RU 28965), a macrolide, against Toxoplasma gondii infection in mice.
    Chan J; Luft BJ
    Antimicrob Agents Chemother; 1986 Aug; 30(2):323-4. PubMed ID: 3767344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro activity of roxithromycin against Toxoplasma gondii in mice.
    Luft BJ
    Eur J Clin Microbiol; 1987 Aug; 6(4):479-81. PubMed ID: 3665901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro and in-vivo activities of roxithromycin in combination with pyrimethamine or sulphadiazine against Toxoplasma gondii.
    Romand S; Bryskier A; Moutot M; Derouin F
    J Antimicrob Chemother; 1995 Jun; 35(6):821-32. PubMed ID: 7559193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of roxithromycin on acute toxoplasmosis in mice.
    Chang HR; Pechere JC
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1147-9. PubMed ID: 3662475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental evaluation of roxithromycin combined with dapsone or sulphamethoxazole on Pneumocystis carinii and Toxoplasma gondii dual infections in a rat model.
    Brun-Pascaud M; Chau F; Derouin F; Girard PM
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():57-62. PubMed ID: 9579714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis.
    Araujo FG; Remington JS
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1672-3. PubMed ID: 1656872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.
    Araujo FG; Slifer T
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2696-701. PubMed ID: 8593005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of spiramycin against Toxoplasma gondii in vitro, in experimental infections and in human infection.
    Chang HR; Pechère JC
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():87-92. PubMed ID: 3182450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model].
    Rodríguez-Díaz JC; Martínez-Grueiro MM; Martínez-Fernández AR
    Enferm Infecc Microbiol Clin; 1993 Dec; 11(10):543-6. PubMed ID: 8142504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii.
    Romand S; Della Bruna C; Farinotti R; Derouin F
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2015-20. PubMed ID: 8878573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic combination of azithromycin and sulfadiazine for treatment of toxoplasmosis in mice.
    Araujo FG; Lin T; Remington JS
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):71-3. PubMed ID: 1314177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy of atovaquone alone or in combination with azithromycin against acute murine toxoplasmosis.
    Moshkani SK; Dalimi A
    Vet Res Commun; 2000 Apr; 24(3):169-77. PubMed ID: 10836275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis.
    Israelski D; Remington J
    Eur J Clin Microbiol Infect Dis; 1990 May; 9(5):358-60. PubMed ID: 2115442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS commentary. Toxoplasmic encephalitis.
    Luft BJ; Remington JS
    J Infect Dis; 1988 Jan; 157(1):1-6. PubMed ID: 3121758
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxoplasma gondii: the effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model.
    Martins-Duarte ÉS; de Souza W; Vommaro RC
    Exp Parasitol; 2013 Mar; 133(3):294-9. PubMed ID: 23270807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of clindamycin and josamycin in experimental Toxoplasma gondii infections].
    Terragna A; Canessa A; Terragna FM; Corradino L
    Minerva Med; 1984 Oct; 75(39):2305-8. PubMed ID: 6504394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of atovaquone and astragalus combination on the treatment and IL-2, IL-12, IFN-γ levels on mouse models of acute toxoplasmosis].
    Sönmez N; Büyükbaba Boral O; Kaşali K; Tekeli F
    Mikrobiyol Bul; 2014 Oct; 48(4):639-51. PubMed ID: 25492659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.